Public Notice from LaPorte County Health Department
The Centers for Disease Control and Prevention (CDC), the Advisory Committee on Immunization Practices (ACIP) and U.S. Food and Drug Administration (FDA) approved a third dose of COVID-19 mRNA vaccines for people who are moderately to severely immunocompromised. Patients who are eligible have completed a two-dose series of a COVID-19 mRNA vaccine 28 days or more prior to the additional dose AND are considered moderately to severely immunocompromised. This includes people who have: Been receiving active cancer treatment for tumors or cancers of the blood Received an organ transplant and are taking medicine to suppress the immune system Received a stem cell transplant within the last
